FibroGen Market Cap

FibroGen has a market cap or net worth of 24.28 million as of April 25, 2025. Its market cap has decreased by -80.92% in one year.

Market Cap

24.28M

Enterprise Value

85.67M

Revenue

23.66M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.32

Market Cap Chart

Since November 14, 2014, FibroGen's market cap has decreased from 1.25B to 24.28M, a decrease of -98.05%. That is a compound annual growth rate of -31.41%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	23.29M	-45.36%
Dec 31, 2024	42.62M	-37.71%
Dec 29, 2023	68.43M	-94.52%
Dec 30, 2022	1.25B	29.40%
Dec 31, 2021	965.40M	-60.95%
Dec 31, 2020	2.47B	-12.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	160.68B
GSK plc	55.88B
Haleon	34.34B
Smith & Nephew	8.78B
ConvaTec Group	5.22B
Hikma Pharmaceuticals	4.20B
HUTCHMED (China)	1.98B
Oxford Nanopore Technologies	1.15B

Market Cap Rankings